229 related articles for article (PubMed ID: 31313060)
1. Fractionated stereotactic radiotherapy for local control of resected brain metastases.
Traylor JI; Habib A; Patel R; Muir M; Gadot R; Briere T; Yeboa DN; Li J; Rao G
J Neurooncol; 2019 Sep; 144(2):343-350. PubMed ID: 31313060
[TBL] [Abstract][Full Text] [Related]
2. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
3. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
[TBL] [Abstract][Full Text] [Related]
4. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
6. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
7. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
[TBL] [Abstract][Full Text] [Related]
12. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
[TBL] [Abstract][Full Text] [Related]
13. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
[TBL] [Abstract][Full Text] [Related]
14. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
15. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
[TBL] [Abstract][Full Text] [Related]
16. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
19. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
20. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
